ThePICenter.com: A Nationwide Network of Legal Representation for Accidents and Injuries Home | Refer to a Friend | Contact Us | Attorney Log-In
ThePICenter - The Personal Injury Center  

Call us today: 877.888.5936 
 Cases We Handle  Why Choose Us  About Us  Client Services  Frequently Asked Questions   Free Case Evaluation - Submit Your Case
Abilify
Has Abilify Caused You Or A Loved One Harm?
Fill Out The Form Below For A Free Evaluation
 
Areas of Expertise
Accidents
Consumer Fraud
Medical Malpractice
Toxic Substances
Unsafe Drugs
Unsafe Products
 
Have a case, but would like to speak with us directly?
 
Call us today: 877.888.5936
 
Click here to receive your free evaluation
 
Unsafe Drugs :: Abilify

ABILIFY - WE ARE NO LONGER ACCEPTING ABILIFY INQUIRIES OR CASES!

In late 2003 the Food and Drug Administration approved the use of the drug Aripiprazole, which is better known to the public as the prescription medication Abilify. Manufactured by both Bristol-Myers Squibb Co. and Otsuka America Pharmaceuticals Inc., Abilify is available in a variety of forms including oral tablets, an oral solution, or as an injection solution for intramuscular injection. Used to treat schizophrenia and more recently approved for bipolar disorder and depression, Abilify is certainly not without its share of potentially serious side effects.

First of all, it is important to understand that the risk of suicidal thoughts and suicidal behavior, especially in adolescents and young adults is much more prevalent in patients that have been using any kind of anti-depressant medication, Abilify included. Because of this, it is recommended that Abilify only be taken by those that are at least 24 years of age or older.  Prescribing the drug to someone younger than that may be medical malpractice.  And prescribing the drug Abilify without prescribing other drugs first, may be medical malpractice.  Abilify should only be prescribed as a last resort and with great care.

It is also important to note that an increased mortality rate has been seen amongst dementia patients who use prescription anti-depressants or antipsychotics, including the drug Abilify. Evidence can be seen in this from the results of 10-week clinical trial where it was found that the rate of death amongst those who had been treated with an anti-depressant was almost 2% higher than those who had only taken a placebo; researchers say this is particularly prevalent amongst elderly women.

Other studies have revealed even more dangers associated with Abilify and other antipsychotics and anti-depressant medication. This includes an increased risk of stroke, Hyperglycemia and Diabetes Mellitus amongst elderly patients, as well.

The best thing that you or a loved one can do before taking any kind of medication, whether it is over-the-counter or prescription is to properly educate yourself on the drug; no matter how innocent it may seem. For some it is too late, however – and if you or someone you know has suffered from any of the serious side effects that are associated with the drug Abilify, it is important that you seek out the appropriate legal help immediately.

Court cases dealing with potential death as a result of Abilify or any other drug are an important matter, and this is a legal issue that requires the serious and professional attention of a fully-qualified Abilify attorney. Fill out our form below for a free case evaluation and analysis by experienced attorneys working on Abilify lawsuits. 

Keywords: Abilify | Abilify Tardive Dyskinesia | Abilify Attorneys | Abilify Lawsuit | Abilify Law Firm
 

Free Case Evaluation

Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.

Your Name:
Your Address:
Your City:
Your State:
Your Zipcode:
Your Email:
Your Phone Number:
Your Fax Number:
Date of Injury:  
Location of Injury:  
If this inquiry is not for yourself, please tell us the name of the person injured:
Your relationship to this person:
 
Details of Injury:
   
Enter the code shown:

Please note, this form may take a few seconds to process after the Submit Case button is pressed.
 


Abilify In the News

Colorado's monitoring of psychotropics trails other states' efforts - Brush News-Tribune
Colorado's monitoring of psychotropics trails other states' effortsBrush News-TribuneJust because the federal Food and Drug Administration has approved a drug for use by children and adolescents doesn't mean...
More Information »



25% of Colorado foster kids on psychotropic - Anchorage Daily News
25% of Colorado foster kids on psychotropicAnchorage Daily NewsDENVER — A University of Colorado analysis found that more than 25 percent of Colorado's foster children in 2012 were prescribed psychotropic drugs and that...
More Information »



Alkermes Antipsychotic Treatment Shows Positive Results -- Update - Wall Street Journal
Drug Discovery & DevelopmentAlkermes Antipsychotic Treatment Shows Positive Results -- UpdateWall Street JournalBased on the results of the 12-week study, the Dublin-based biopharmaceutical company said it expects to submit a...
More Information »



New thinking on brain-science therapies could help foster kids - The Denver Post
New thinking on brain-science therapies could help foster kidsThe Denver PostThose symptoms are controlled through potent antipsychotics and antidepressants including Risperdal, Abilify and Zoloft, drugs sometimes prescribed...
More Information »



Brand Name vs Generic Drugs: Which Is Better? - Automated Trader (blog)
Brand Name vs Generic Drugs: Which Is Better?Automated Trader (blog)Prescription and over-the-counter drugs cannot be sold to the public unless they have been approved by the Federal Drug Administration (FDA). Period. Whether...
More Information »



25% of Colorado foster kids on psychotropic drugs - ModernHealthcare.com
25% of Colorado foster kids on psychotropic drugsModernHealthcare.comA University of Colorado analysis found that more than 25% of Colorado's foster children in 2012 were prescribed psychotropic drugs and that about half...
More Information »



Market Update (NYSE:BMY): Bristol-Myers Squibb Submits NDAs for Daclatasvir ... - Jutia Group
Market Update (NYSE:BMY): Bristol-Myers Squibb Submits NDAs for Daclatasvir ...Jutia Group[Business Wire] – Bristol-Myers Squibb Company announced today that they have submitted new drug applications with the U.S. Food and...
More Information »



Research and Markets: Opportunity Analyzer: Autism Spectrum Disorder ... - Business Wire (press release)
Research and Markets: Opportunity Analyzer: Autism Spectrum Disorder ...Business Wire (press release)The patent expiries of Abilify (aripiprazole) and Namenda will lead to decreased sales as a result of generic erosion. -...
More Information »



Simvastatin may slow progression of multiple sclerosis - News-Medical.net
Simvastatin may slow progression of multiple sclerosisNews-Medical.netResults of a phase 2 study published in The Lancet suggest that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for...
More Information »



โรคอารมณ์สองขั้ว (Bipolar Disorder) เสี่ยงต่อการฆ่าตัวตาย!!!?? - วิชาการ.คอม
วิชาการ.คอมโรคอารมณ์สองขั้ว (Bipolar Disorder) เสี่ยงต่อการฆ่าตัวตาย!!!??วิชาการ.คอม2.1 Valproic acid หรือ divalproex sodium (Depakote) ใน FDA กล่าวว่าใช้รักษาอาการคลุ้มคลั่งและเป็นอีกตัวเลือกหนึ่งแทน lithium...
More Information »

 









 
Aviation Accidents| Car Accidents| Truck Accidents| Birth Injuries| Nursing Home Negligence| Mesothelioma| Defective Medical Devices
Copyright 2011 Steppacher Law Offices LLC. All Rights Reserved.
The Personal Injury Center of AmericaTM is proud to serve clients in New York, Los Angeles, Chicago, Houston, Philadelphia, and throughout the nation.